Institutional Ownership
Alto Neuroscience Inc
CUSIP 02157Q109COM SHSANROQ1 2026
13D / 13G Filings
24
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
13.8%
Max % of class reported
Institutional Holders
107
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
24 filings · latest Feb 18, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 18, 2026 | Armistice Capital, LLC | 13G/A | 4.9% | 1.54M | SEC |
| 2 | Feb 17, 2026 | Commodore Capital LP | 13G/A | 11.0% | 3.25M | SEC |
| 3 | Feb 17, 2026 | Perceptive Advisors LLC | 13G/A | 10.0% | 3.25M | SEC |
| 4 | Feb 17, 2026 | K2 Healthventures Equity Trust LLC | 13G/A | 2.4% | 789.0K | SEC |
| 5 | Feb 17, 2026 | Point72 Asset Management, L.P. | 13G/A | 8.9% | 2.82M | SEC |
| 6 | Feb 17, 2026 | Vestal Point Capital, LP | 13G | 8.0% | 2.48M | SEC |
| 7 | Oct 27, 2025 | Commodore Capital LP | 13G | 11.0% | 3.19M | SEC |
| 8 | Oct 10, 2025 | Perceptive Advisors LLC | 13G | 7.3% | 1.99M | SEC |
| 9 | Aug 14, 2025 | Armistice Capital, LLC | 13G/A | 7.0% | 2.00M | SEC |
| 10 | Jul 16, 2025 | Blackrock, Inc. | 13G/A | 2.1% | 561.4K | SEC |
14 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Alto Neuroscience Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Alpha Wave Global, LP | 3.71M | $83.35M |
| 2 | Commodore Capital LP | 2.72M | $61.22M |
| 3 | Vestal Point Capital, LP | 2.06M | $46.40M |
| 4 | Perceptive Advisors LLC | 2.01M | $45.18M |
| 5 | Spruce Street Capital LP | 1.33M | $29.12M |
| 6 | Franklin Resources Inc | 1.10M | $24.77M |
| 7 | Vivo Capital, LLC | 1.04M | $23.28M |
| 8 | Armistice Capital, LLC | 912.0K | $20.50M |
| 9 | Millennium Management LLC | 822.0K | $18.48M |
| 10 | 72 Investment Holdings, LLC | 667.8K | $15.01M |